Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | malonyl-CoA decarboxylase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | importin-beta 2, putative | 0.0029 | 0.0114 | 0.5 |
Trypanosoma cruzi | malonyl-CoA decarboxylase, mitochondrial precursor, putative | 0.0198 | 0.3633 | 1 |
Loa Loa (eye worm) | glutaminase | 0.0274 | 0.5214 | 0.5159 |
Toxoplasma gondii | HEAT repeat-containing protein | 0.0029 | 0.0114 | 0.5 |
Schistosoma mansoni | glutaminase | 0.0274 | 0.5214 | 0.8765 |
Brugia malayi | glutaminase DH11.1 | 0.0274 | 0.5214 | 0.5159 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | malonyl-CoA decarboxylase | 0.0504 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0504 | 1 | 1 |
Echinococcus granulosus | snurportin 1 | 0.0309 | 0.5933 | 1 |
Trypanosoma cruzi | malonyl-CoA decarboxylase, mitochondrial precursor, putative | 0.0198 | 0.3633 | 1 |
Echinococcus multilocularis | snurportin 1 | 0.0309 | 0.5933 | 1 |
Plasmodium falciparum | importin beta, putative | 0.0029 | 0.0114 | 0.5 |
Loa Loa (eye worm) | glutaminase 2 | 0.0274 | 0.5214 | 0.5159 |
Mycobacterium ulcerans | glutaminase | 0.0274 | 0.5214 | 0.5 |
Brugia malayi | RNA, U transporter 1 | 0.0082 | 0.1223 | 0.1122 |
Loa Loa (eye worm) | nucleolar RNA-associated protein alpha | 0.0309 | 0.5933 | 0.5886 |
Leishmania major | malonyl-coa decarboxylase-like protein | 0.0198 | 0.3633 | 1 |
Trypanosoma brucei | malonyl-CoA decarboxylase, mitochondrial precursor, putative | 0.0198 | 0.3633 | 1 |
Trichomonas vaginalis | glutaminase, putative | 0.0274 | 0.5214 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0309 | 0.5933 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.